palmitoylethanolamide.com.au
HomeResearchNiclas 2022

Investigating the Long-Term Effect of an Interdisciplinary Multimodal Rehabilitation Program on Levels of Bioactive Lipids and Telomerase Activity in Blood from Patients with Chronic Pain

Niclas Stensson, Björn Gerdle, Linn Rönne-Petersén, Liu L Yang, Catharina Lavebratt, Torkel Falkenberg, Bijar Ghafouri. J Clin Med. 2022 Feb 26;11(5):1291.

Open-label, no control groupHumans

Design
Open-label, no control group
Subjects
18 patients with complex chronic pain taking part in a rehabilitation programme
Dose used in the study
Not stated in the abstract; no palmitoylethanolamide was given
Duration
Six-month follow-up
What was measured
Plasma AEA, 2-AG, palmitoylethanolamide, OEA, SEA and telomerase activity, plus self-reported pain, psychological distress and physical activity before the programme and at six months.

What the authors reported

This open-label study found:

  • Pain intensity fell and SEA levels rose at six months, and the two changes were correlated.
  • AEA was inversely correlated with physical activity.
  • 2-AG and telomerase activity were correlated at follow-up.
  • No change in palmitoylethanolamide was reported.

Limits of this study

A small exploratory study with no control group; it measured natural palmitoylethanolamide and did not test PEA as a treatment. The authors declare no conflict of interest.

Source

PubMed 35268382 · doi:10.3390/jcm11051291

Entry checked against the abstract on PubMed on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.